Dr. Stanley Chaleff, MD
Claim this profileMaine Children's Cancer Program
Studies Brain Tumor
Studies Low Grade Glioma
6 reported clinical trials
14 drugs studied
Area of expertise
1Brain Tumor
Stage IV
NTRK positive
ALK positive
2Low Grade Glioma
Stage IV
BRAF negative
Stage I
Affiliated Hospitals
Clinical Trials Stanley Chaleff, MD is currently running
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Selumetinib + Vinblastine
for Low-Grade Glioma
This phase III trial investigates the best dose of vinblastine in combination with selumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinib alone in treating children and young adults with low-grade glioma (a common type of brain cancer) that has come back after prior treatment (recurrent) or does not respond to therapy (progressive). Selumetinib is a drug that works by blocking a protein that lets tumor cells grow without stopping. Vinblastine blocks cell growth by stopping cell division and may kill cancer cells. Giving selumetinib in combination with vinblastine may work better than selumetinib alone in treating recurrent or progressive low-grade glioma.
Recruiting2 awards Phase 339 criteria
More about Stanley Chaleff, MD
Clinical Trial Related4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Stanley Chaleff, MD has experience with
- Selumetinib
- Repotrectinib
- Carboplatin; Vincristine Sulfate
- Carboplatin; Vincristine
- Selumetinib Sulfate
- Vinblastine Sulfate
Breakdown of trials Stanley Chaleff, MD has run
Brain Tumor
Low Grade Glioma
Tumors
Astrocytoma
Central Nervous System Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stanley Chaleff, MD specialize in?
Stanley Chaleff, MD focuses on Brain Tumor and Low Grade Glioma. In particular, much of their work with Brain Tumor has involved Stage IV patients, or patients who are NTRK positive.
Is Stanley Chaleff, MD currently recruiting for clinical trials?
Yes, Stanley Chaleff, MD is currently recruiting for 5 clinical trials in Scarborough Maine. If you're interested in participating, you should apply.
Are there any treatments that Stanley Chaleff, MD has studied deeply?
Yes, Stanley Chaleff, MD has studied treatments such as Selumetinib, Repotrectinib, Carboplatin; Vincristine Sulfate.
What is the best way to schedule an appointment with Stanley Chaleff, MD?
Apply for one of the trials that Stanley Chaleff, MD is conducting.
What is the office address of Stanley Chaleff, MD?
The office of Stanley Chaleff, MD is located at: Maine Children's Cancer Program, Scarborough, Maine 04074 United States. This is the address for their practice at the Maine Children's Cancer Program.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.